Haberler      English      العربية      Pусский         Kurdî      Türkçe Delivering News and Insights Around the World Keltis
  En.Haberler.Com - Latest News
SEARCH IN NEWS:
  HOME PAGE 08/03/2021 18:21 
22.02.2021 17:12 News >> Sanofi To Produce Johnson & Johnson's Vaccine In France

Sanofi To Produce Johnson & Johnson's Vaccine In France

French drugmaker to offer its manufacturing plant to fill vials of COVID 19 vaccine, plans to produce 12M doses per month.

French drugmaker Sanofi on Monday said it will provide support in manufacturing the COVID-19 vaccine developed by its American rival Johnson & Johnson to help address global supply demands.
In a statement, Sanofi announced partnership with Johnson & Johnson's Janssen pharmaceutical NV and Janssen pharmaceuticals, Inc; and that it is awaiting approval from the US and European authorities to produce and market the vaccine.

Once authorized, the statement said, the French drugmaker will provide Johnson & Johnson access to its vaccine manufacturing plant in Lyon city to formulate and fill vials of Janssen's vaccine candidate, producing approximately 12 million doses per month.

This is the second partnership for Sanofi with its rival as its own vaccine candidate faces delays. In January, it entered a similar agreement to provide manufacturing support to the vaccine jointly produced by Pfizer and BioNTech.
Sanofi also said it has resumed Phase 2 trial on Monday on its own COVID-19 vaccine together with Britain's GSK.
The new study will evaluate the safety, reactogenicity, and immunogenicity of the vaccine in 720 volunteers aged 18-59. Based on the results, the company said it hopes to start Phase 3 trial and make the vaccine available towards the end of 2021.

An earlier trial of the vaccine candidate, which is based on technology used to produce seasonal influenza vaccines and on immunological agents, had shown "a low immune response in older adults."

The company said it has also commenced "development work against new variants [of the virus], which will be used to inform next stages of the Sanofi/GSK development program." -



        Latest News
US Stock Market Opens Mixed With Inflation Concerns 12 minutes ago...
Biden's $1.9 trillion relief package has increased concerns that inflation could increase in world's largest economy.
Indonesia: Muslim Body Calls To Help Hunger-Hit Yemenis -33 minutes ago...
Indonesian Ulema Council asks Islamic, humanitarian bodies to raise funds and help people in Yemen starving due to war.
Libyan Parliament Convenes To Vote On New Government -33 minutes ago...
Session kicks off with presence of 132 lawmakers out of 200.
Turkey: Greece Deploying Navy Boats Near Turkish Coast -18 minutes ago...
Athens sending assault boats to demilitarized islands in east Aegean in 'provocative and unlawful' actions, says official.
EU Council Head Pays Tribute To Rwanda Genocide Victims -3 minutes ago...
'Never stop remembering, every day, the worst humanity has done,' says Charles Michel.

 
      Top News
Football: Results In Top 5 European Leagues Football: Results In Top 5 European Leagues
Philippines Gets More Doses Of Astrazeneca Vaccines Philippines Gets More Doses Of Astrazeneca Vaccines
Int'l Event Bosphorus Summit Starts In Istanbul Int'l Event Bosphorus Summit Starts In Istanbul
Another Conflict Grips Kashmir But On Mutton This Time Another Conflict Grips Kashmir But On Mutton This Time
Cameroon Woman Defies Odds To Pursue Medical Dream Cameroon Woman Defies Odds To Pursue Medical Dream
Turkey Condoles With Equatorial Guinea Over Explosions Turkey Condoles With Equatorial Guinea Over Explosions
Nigel Farage Steps Down From Frontline UK Politics Nigel Farage Steps Down From Frontline UK Politics
Syria: 18 People Killed In Mine Blasts Syria: 18 People Killed In Mine Blasts
Pope Francis Calls For Peace Amid Ruins Of Iraq's Mosul Pope Francis Calls For Peace Amid Ruins Of Iraq's Mosul
Joe Biden Needs To Walk The Democracy Walk In Myanmar Joe Biden Needs To Walk The Democracy Walk In Myanmar